The groundbreaking therapy of this peptide represents a major development in the handling of type 2 diabetes. Different to existing drugs, tirzepatide targets two pathways – glucagon-like peptide-1 (GLP-1) and GIP https://tirzepatide-peptide372752.bloggin-ads.com/65179926/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment